One of the world’s most prestigious and celebrated awards, the Nobel Prize is given to those who “have conferred the greatest benefit on mankind.” It is no surprise, then, that UC San Diego—which is ranked by Washington Monthly as the top university in the nation for public service—is home to an impressive number of Nobel laureates.
Lisa Murphy, associate administrator for University of California, San Diego Health System and administrative director for Cardiovascular and Medicine Services, has been chosen “Woman of the Year” in the field of health care by the Women in Leadership program sponsored by the San Diego East County Chamber of Commerce.
The Institute of Medicine (IOM) today announced the names of 70 new members and 10 foreign associates during its 42nd annual meeting. Included are two new members from the University of California, San Diego School of Medicine: David A. Brenner, MD, vice chancellor for Health Sciences and dean of the UCSD School of Medicine, and Don W. Cleveland, PhD, chair of the UCSD Department of Cellular and Molecular Medicine, and professor of medicine, neurosciences, and cellular and molecular medicine at the Ludwig Institute for Cancer Research.
At the University of California, San Diego, two University of California, San Diego scientists have received a $1 million grant from the W.M. Keck Foundation to fund research into exploring a molecular approach to delivering drugs into cells that could change the pharmaceutical industry worldwide. The W.M. Keck Foundation of Los Angeles supports “high risk/high reward” pioneering discoveries in groundbreaking studies that enable researchers to translate their innovative ideas into real world impact.
The University of California, San Diego division of the California Institute for Telecommunications and Information Technology (Calit2) has given the green light to 17 new projects funded through the Calit2 Strategic Research Opportunities (CSRO) program. All told, the winning proposals garnered more than $826,000 in support from Calit2 for the year-long projects, effective October 1, 2012.
An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for a broad-based effort designed to better understand the pathology of CLL – the most common form of leukemia in the Western world – and develop new drugs and treatments.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
